Periconceptional folic acid supplementation: knowledge, attitudes and counselling practice of Serbian pharmacists and pharmacy technicians

Milica T Zeković; Dušanka Krajnović; Marina Nikolić; Tatjana Stojković; Mirjana Gurinović; Marija Glibetić

doi:10.2298/VSP171226020Z

Milica T Zeković University of Belgrade, Institute for Medical Research, Centre of Research Excellence in Nutrition and Metabolism, Belgrade, Serbia
Dušanka Krajnović University of Belgrade, Faculty of Pharmacy, Department of Social Pharmacy and Pharmaceutical Legislation, Belgrade, Serbia
Marina Nikolić University of Belgrade, Institute for Medical Research, Centre of Research Excellence in Nutrition and Metabolism, Belgrade, Serbia
Tatjana Stojković University of Belgrade, Faculty of Pharmacy, Department of Social Pharmacy and Pharmaceutical Legislation, Belgrade, Serbia
Mirjana Gurinović University of Belgrade, Institute for Medical Research, Centre of Research Excellence in Nutrition and Metabolism, Belgrade, Serbia
Marija Glibetić University of Belgrade, Institute for Medical Research, Centre of Research Excellence in Nutrition and Metabolism, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP171226020Z

Keywords: community pharmacy services, pharmacists, pharmacy technicians, health knowledge, attitudes, practice, folic acid, pregnancy, serbia

Abstract

Abstract

Background/Aim. The protective effect of periconceptional folic acid supplementation in reducing the risk of neural tube defects (NTDs) and other adverse pregnancy outcomes has been scientifically confirmed. The present study aimed to assess knowledge, attitudes, and practice (KAP) of community pharmacists and pharmacy technicians with regards to counselling women of reproductive age on adequate folate intake. Methods. The cross-sectional study was conducted among the nationwide stratified sample of pharmacists and pharmacy technicians, practicing in both private and state-owned community pharmacies in Serbia. The detailed literature review, expert consultation and pre-testing were employed in the questionnaire development. The descriptive and inferential statistical analyses were performed using the SPSS software ver. 22. Results. Among 730 survey participants, 96.6% correctly identified types of deformities that could be prevented by folic acid and 77.0% recognized recommended dosage for women capable of becoming pregnant. However, fewer were able to recognize the optimal timing for folic acid supplementation (61.1%) and the proper dose for the NTD recurrence prevention (42.9 %). While 43.2% of pharmacy technicians thought that it was not their responsibility to provide a counselling concerning the measures for the prevention of congenital anomalies, only 4.7% of licensed pharmacists and none of the interns were of that opinion (χ² = 198.287; df = 4; p < 0.001). The majority of respondents (54.7%) reported provision of informative consultation concerning folic acid once a week, or few times a month, while only 10 stated to do so on a daily basis. In addition, based on self-report, only 36.7% of participants communicates information and advice regarding adequate folate status at their own initiative, while the rest addresses this topic only on the patients request, i.e., reactively. Conclusion. Although participants acknowledged the importance of their role in preconception health promotion, our findings revealed certain knowledge gaps as well as dominantly reactive counselling practice. Tailored educational interventions and professional support are needed to improve the engagement of community pharmacy personnel in this area of public health.

Author Biography

Milica T Zeković, University of Belgrade, Institute for Medical Research, Centre of Research Excellence in Nutrition and Metabolism, Belgrade, Serbia

References

REFERENCES

Safi J, Joyeux L, Chalouhi GE. Periconceptional folate deficiency and implications in neural tube defects. J Pregnancy 2012; 2012: 295083.

Lucock M. Folic acid: nutritional biochemistry, molecular biol-ogy, and role in disease processes. Mol Genet Metab 2000; 71(1–2): 121–38.

Blom HJ. Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol Teratol 2009; 85(4): 295–302.

Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann 2010; 41(4): 241–50.

Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006; 367(9519): 1352–61.

Cornel MC, de Smit DJ, de Jong-van den Berg LT. Folic acid--the scientific debate as a base for public health policy. Reprod Toxicol 2005; 20(3): 411–5.

World Health Organization, Food and Agriculture Organization of the United Nations. The Rome Declaration on Nutrition. ICN2 Second International Conference on Nutrition better nutrition, better lives; Rome, Italy; 2014 November 19–21. Rome: Food and Agriculture Organization of the United Nations; 2014.

DiPietro Mager NA. Fulfilling an Unmet Need: Roles for Clini-cal Pharmacists in Preconception Care. Pharmacotherapy 2016; 36(2): 141–51.

Gomes S, Lopes C, Pinto E. Folate and folic acid in the pericon-ceptional period: recommendations from official health organ-izations in thirty-six countries worldwide and WHO. Public Health Nutr 2016; 19(1): 176–89.

Chitayat D, Matsui D, Amitai Y, Kennedy D, Vohra S, Rieder M, et al. Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update. J Clin Pharmacol 2016; 56(2): 170–5.

McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008; 99 Suppl 3: S48–54.

Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 2004; 111(5): 399–408.

De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supple-mentation for preventing birth defects. Cochrane Database Syst Rev 2015; (12): CD007950.

Bailey LB, Stover PJ, McNulty H, Fenech MF, Gregory JF 3rd, Mills JL, et al. Biomarkers of Nutrition for Development-Folate Review. J Nutr 2015; 145(7): 1636S–80S.

Obeid R, Pietrzik K, Oakley GP Jr, Kancherla V, Holzgreve W, Wieser S.Preventable spina bifida and anencephaly in Europe. Birth Defects Res A Clin Mol Teratol 2015; 103(9): 763–71.

Zekovic M, Djekic-Ivankovic M, Nikolic M, Gurinovic M, Krajnovic D, Glibetic M. Validity of the Food Frequency Questionnaire Assessing the Folate Intake in Women of Reproductive Age Living in a Country without Food Fortification: Application of the Method of Triads. Nutrients 2017; 9(2): pii: E128.

Odalovic M, Vezmar Kovacevic S, Ilic K, Sabo A, Tasic L. Drug use before and during pregnancy in Serbia. Int J Clin Pharm 2012; 34(5): 719–27.

FIP. Statement of Policy on the effective utilization of phar-macists in improving maternal, newborn and child health (MNCH). FIP, International Pharmaceutical Federation; 2013. Available from: www.fip.org/statements

World Health Organization. European strategic approach for making pregnancy safer: improving maternal and perinatal health. Denmark, Copenhagen: World Health Organization; 2008.

Krejcie R, Daryle M. Determining sample size for research activities. Educ Psychol Meas 1970; 30(3): 607–10.

Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res 2010; 1(2): 67–9.

Bolarinwa OA. Principles and methods of validity and reliability testing of questionnaires used in social and health science researches. Niger Postgrad Med J 2015; 22(4): 195–201.

World Health Organization. Standards and operational guidance for ethics review of health-related research with human partic-ipants. Switzerland, Geneva: World Health Organization; 2011.

Kelling SE, Rondon-Begazo A, DiPietro Mager NA, Murphy BL, Bright DR. Provision of Clinical Preventive Services by Com-munity Pharmacists. Prev Chronic Dis 2016; 13: E149.

Royal Society for Public Health. Building capacity: realising the potential of community pharmacy assets for improving the public’s health. London, UK: RSPH; 2016.

Deeks LS, Cooper GM, Currie MJ, Martin SJ, Parker RM, Del Rosario R, et al. Can pharmacy assistants play a greater role in public health programs in community pharmacies? Lessons from chlamydia screening study in Canberra, Australia. Res Social Adm Pharm 2014; 10(5): 801–6.

McNulty H. The role of food fortification: the example of folic acid. In: Biesalski HK, Drenowski A, Dwyer JT, Strain J, Weber P, Eggersdorfer M, editors. Sustainable nutrition in a changing world. Cham: Springer International Publishing; 2017. p. 371–88.

Rodrigues CR, Dipietro NA. Knowledge of folic acid and coun-seling practices among Ohio community pharmacists. Pharm Pract (Granada) 2012; 10(3): 168–72.

Lynch SM. Assessment of student pharmacists' knowledge con-cerning folic acid and prevention of birth defects demon-strates a need for further education. J Nutr 2002; 132(3): 439–42.

Power ML, Holzman GB, Schulkin J. Knowledge and clinical practice regarding folic acid among obstetrician-gynecologists. Obstet Gynecol 2000; 95(6 Pt 1): 895–8.

Li T, Zhu J, Zeng Z, Wang Y, Liang J, Yuan P. Study of KAP with regard to taking folic acid supplements and factors affecting the recommendation and prescription of those supplements among obstetricians and specialists in women's health in six provinces of Northern China, 2009. Biosci Trends 2011; 5(3): 104–10.

Abu-Hammad T, Dreiher J, Vardy DA, Cohen AD. Physicians' knowledge and attitudes regarding periconceptional folic acid supplementation: a survey in Southern Israel. Med Sci Monit 2008; 14(5): CR262–7.

Demilew YM, Asres Nigussie A. Knowledge of Health Profes-sionals on Folic Acid Use and Their Prescribing Practice in Bahir Dar City Administration, Northwest Ethiopia: Cross-Sectional Study. PLoS One 2017; 12(1): e0170116.

Pardo R, Lay-Son G, Aranda W, Recabal P, Navarrete M, Tenhamm T, et al. Chilean primary health workers' knowledge about folic acid supplementation for the prevention of neural tube defects. Am J Med Genet A 2006; 140(11): 1238–40.

Boykin CM, DiPietro Mager NA. Ohio pharmacy students’ knowledge of folic acid and neural tube defects. Curr Pharm Teach Learn 2015; 7(2): 273–6.

Williams JL, Abelman SM, Fassett EM, Stone CE, Petrini JR, Damus K, et al. Health care provider knowledge and practices regarding folic acid, United States, 2002-2003. Matern Child Health J 2006; 10(Suppl 7): 67–72.

De Jong-van den Berg LT, Van der Zee AH, Schaafsma E, De Smit D, Anderson C, Cornel MC. Counselling women about pericon-ceptional use of folic acid: The role of the community phar-macist can be improved. Int J Pharm Pract 1999; 7(3): 138–142.

Bitzer J, von Stenglin A, Bannemerschult R. Women's awareness and periconceptional use of folic acid: data from a large Euro-pean survey. Int J Womens Health 2013; 5: 201–13.

Eades CE, Ferguson JS, O'Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health 2011; 11: 582.

Anderson C, Rajyaguru R. The role of community pharmacists and medicines counter assistants in health promotion: reflec-tions from a folic acid campaign. Int J Pharm Pract 2002; 10(1): 17–22.

Meijer WM, de Smit DJ, Jurgens RA, Lolkje TV, de Jong-van den Berg LT. Pharmacists' role in improving awareness about folic acid: a pilot study on the process of introducing an interven-tion in pharmacy practice. Int J Pharm Pract 2004; 12(1): 29–35.

Laliberté MC, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health 2012; 12: 192.

Bixenstine PJ, Cheng TL, Cheng D, Connor KA, Mistry KB. Association Between Preconception Counseling and Folic Acid Supplementation Before Pregnancy and Reasons for Non-Use. Matern Child Health J 2015; 19(9): 1974–84.

Erku DA, Mersha AG. Involvement of community pharmacists in public health priorities: A multi-center descriptive survey in Ethiopia. PLoS One 2017; 12(7): e0180943.

Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Stein-hardt M. Examination of pharmacists' intention to report se-rious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm 2011; 7(4): 369–82.

Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database. Res Social Adm Pharm 2014; 10(2): 285–96.

Watson MC, Johnston M, Entwistle V, Lee AJ, Bond CM, Fielding S. Using the theory of planned behaviour to develop targets for interventions to enhance patient communication during pharmacy consultations for non-prescription medicines. Int J Pharm Pract 2014; 22(6): 386–96.

Tan CL, Hassali MA, Saleem F, Shafie AA, Aljadhay H, Gan VB. Building intentions with the theory of planned behaviour: a qualitative assessment of salient beliefs about pharmacy value added services in Malaysia. Health Expect 2016; 19(6): 1215–25.

Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991; 50(2): 179–211.